November is Diabetes Awareness Month. But by the time you have a diabetes diagnosis, the metabolic conversation has already been happening in your body for a decade or longer. The women who arrive at their late fifties without metabolic disease didn’t get lucky. They tracked the right numbers early.
This session covers the metabolic markers that reveal what’s happening now and what’s coming. We’ll walk through the standard tests every doctor orders, the emerging markers that are transforming how leading practitioners assess metabolic risk, and why fasting glucose alone is one of the least useful numbers on your lab report. Perimenopause and menopause change metabolic reality in ways most women aren’t warned about. This session gives you the framework to have the metabolic conversation your doctor may not be initiating.
Standard of care markers we’ll cover include fasting glucose, hemoglobin A1c, and standard lipid panels. Emerging markers include fasting insulin, HOMA-IR calculation, continuous glucose monitoring data, oral glucose tolerance testing with insulin response, adiponectin, high-sensitivity CRP as it relates to metabolic inflammation, and the case for pre-diabetes screening at earlier ages than current guidelines suggest.
You’ll leave with clarity on what your metabolic numbers actually mean, what to ask your doctor to add to your workup, and how to interpret trends over time rather than single results.
